1. 1475PDA randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide and cisplatin (API), followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). Update at 10 years. (18th September 2017) Authors: Pautier, P.; Brard, C.; Floquet, A.; Gladieff, L.; Rios, M.; Piperno-Neumann, S.; Berton-Rigaud, D.; Blay, J-Y.; Fabbro, M.; Lotz, J-P.; Vinceneux, A.; Bertucci, F.; De La Motte Rouge, T.; Guillemet, C.; Genestie, C.; Duffaud, F. Journal: Annals of oncology Issue: Volume 28(2017)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2772 Circulating tumor cells kinetics in ovarian carcinoma: correlation with baseline characteristics and CA-125 levels in the randomized ANTHALYA trial evaluating bevacizumab in the neoadjuvant setting. (September 2015) Authors: Cottu, P.; Rouge, T. De La Motte; Pautier, P.; Provansal, M.; Floquet, A.; Selle, F.; Mouret-Reynier, M.A.; Fabbro, M.; Kalbacher, E.; Piprot, C.; Follana, P.; Lesoin, A.; Medioni, J.; Menguy, V.; Ghazi, Y.; Bidard, F.C.; Dubot, C.; Joly, F. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S555 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Frailty as a Predictor of Postoperative Morbidity and Mortality Following Liver Resection. (2021) Authors: Serrano, P.; Bao, T.; McKechnie, T.; Fabbro, M.; Thieu, C.; Ruo, L. Journal: HPB Issue: Volume 23(2021)Supplement 1 Page Start: S122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Frailty As A Predictor Of Postoperative Outcomes Following Liver Resection. (2020) Authors: Bao, T.; Ruo, L.; Fabbro, M.; Serrano, P.E. Journal: HPB Issue: Volume 22(2020)Supplement 1 Page Start: S29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. High dose chemotherapy in ovarian cancer. (1st July 2001) Authors: Pujade-Lauraine, E.; Curé, H.; Battista, C.; Guastalla, J. P.; Chiurazzi, B.; Fabbro, M.; Tubiana-Mathieu, N.; Bourgeois, H.; Lioure, B.; Paraiso, D.; Lotz, J.P. Journal: International journal of gynecological cancer Issue: Volume 11(2001)Supplement 1 Page Start: 64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Identifying prognostic factors for overall survival in patients with recurrent disease following liver resection for colorectal cancer metastasis. (2021) Authors: Park, L.J.; Daza, J.; Li, V.; Msallak, H.; Zhang, B.; Workneh, A.; Zuk, V.; Faisal, S.; Faisal, R.; Fabbro, M.; Claasen, M.; Hallet, J.; Martel, G.; Sapisochin, G.; Serrano, P.E. Journal: HPB Issue: Volume 23(2021)Supplement 2 Page Start: S584 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗